Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Sep;4(3):355-369.
doi: 10.1007/s40521-017-0140-6. Epub 2017 Aug 1.

Atopic Dermatitis: Early Treatment in Children

Amy Huang  1 , Christine Cho  2 , Donald Y M Leung  2 , Kanwaljit Brar  2
Affiliations

Atopic Dermatitis: Early Treatment in Children

Amy Huang et al. Curr Treat Options Allergy. 2017 Sep.

Abstract

Therapeutic regimens for the treatment and long-term management of AD traditionally had a two-fold objective of decreasing skin inflammation and repairing the defective skin barrier. Essential treatments for AD in children should include topical moisturizers for skin hydration and prevention of flares, topical anti-inflammatory medications (e.g. corticosteroids, calcineurin inhibitors, PDE4 inhibitor), allergen/irritant avoidance, and treatment of skin infections. Treatment regimens should be severity-based, and implemented in a stepwise approach tailored to the individual patient. This stepwise approach includes initial use of emollients, gentle skin care, and escalating to more potent anti-inflammatory treatments as the disease severity increases. Currently available systemic medications should be reserved for the presence of recalcitrance to topical therapies due to associated toxicities. We believe that early treatment of AD is not only essential in treating the skin disease, but also in preventing the development of additional atopic diseases, such as food allergy, asthma and allergic rhinitis. The defective skin barrier of AD permits a route of entry for food and environmental allergens, and upon exposure, keratinocytes secrete TSLP, which activates the TH2 pathway. This TH2 differentiation sets off the atopic march and the subsequent diseases that are seen. This review highlights treatment options and strategies in pediatric AD therapy with an emphasis on early therapy. Supporting evidence on the efficacy and safety of each intervention will be discussed.

Keywords: allergy; atopic dermatitis; atopic march; corticosteroids; eczema; immunosuppression.

PubMed Disclaimer

References

    1. Baron SE, et al. Guidance on the diagnosis and clinical management of atopic eczema. Clin Exp Dermatol. 2012;37(Suppl 1):7–12. - PubMed
    1. Horii KA, et al. Atopic dermatitis in children in the United States, 1997–2004: visit trends, patient and provider characteristics, and prescribing patterns. Pediatrics. 2007;120(3):e527–34. - PubMed
    1. Kay J, et al. The prevalence of childhood atopic eczema in a general population. J Am Acad Dermatol. 1994;30(1):35–9. - PubMed
    1. Lee SC Committee of Korean Atopic Dermatitis Association for R. Various diagnostic criteria for atopic dermatitis (AD): A proposal of Reliable Estimation of Atopic Dermatitis in Childhood (REACH) criteria, a novel questionnaire-based diagnostic tool for AD. J Dermatol. 2016;43(4):376–84. - PubMed
    1. Leung DY, Guttman-Yassky E. Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches. J Allergy Clin Immunol. 2014;134(4):769–79. This paper is an educational discussion on the complex pathogenesis of atopic dermatitis, covering the immunological, microbiological, genetic, and environmental etiologies of the disease. - PMC - PubMed

LinkOut - more resources